Notice is given under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“Act”), of the following application to register a trade name product under section 9(1) of the Act:

Trade Name: Biozest

Reference: P010071

Active Ingredient and Concentration:

23g/L lecithin

Formulation Type: (SC) Suspension concentrate

Application Method / Administration Route: N/A

Use Claim:

Biozest Increases Productivity:

• Biozest improves pasture growth, quality and palatability.
• Biozest increases livestock productivity and milk/meat production.
• Biozest treated pasture is more climate resilient i.e. more productive when under abiotic stress including frost, waterlogging and drought.

Biozest Reduces Environmental Impact:

• Biozest treated pasture is more efficiently converted to milk and meat; therefore, less is wasted as urea/nitrates and methane.
• Biozest increases pasture productivity and density. Therefore, Biozest increases carbon sequestration.
• Biozest increases pasture density and maximises land cover. This increases the utilisation of resources and could result in reduced nutrient loss.

Any person may make a written submission to the director-general concerning this application.

Under sections 16 and 17 of the Act, a written submission:

1. must state in full the reasons for making the submission;
2. may state any decision sought on that application; and
3. must be received by the director-general no later than 30 working days after the date of this notice.

Each submission must state the trade name product(s) to which it relates. Under section 18 of the Act, a copy of every submission will be forwarded to the applicant.

The following address is:

1. where submissions on this application are to be sent;
2. where requests for copies of the public information relating to the application can be sent;
3. where public information relating to the application can be viewed; and
4. the director-general’s address for service:

ACVM Team, Ministry for Primary Industries, Charles Fergusson Building, 38–42 Bowen Street, Pipitea, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140. Email: acvm.consultation@mpi.govt.nz.

MPI encourages submission by email.

The applicant’s address for service is:

Zest Biotech Limited, 1974 Great South Road, Bombay, Auckland 2675. Postal Address: Zest Biotech Limited, PO Box 384, Pukekohe, Auckland 2340.

Dated at Wellington this 24th day of February 2025.

SHALEEN NARAYAN, Ministry for Primary Industries (acting under delegated authority).